Product
TAS5315
Aliases
TAS5315 Dose 1, TAS5315 Dose 2, TAS5315 Dose 3, TAS5315 Dose 4, TAS5315 Dose 5
1 clinical trial
1 indication
Indication
Chronic Spontaneous UrticariaClinical trial
A Phase 2a, Randomized, Double-blind, Study of TAS5315 in Chronic Spontaneous Urticaria Patients With an Inadequate Response to H1-antihistaminesStatus: Recruiting, Estimated PCD: 2024-03-01